These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 15967113)
41. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879 [TBL] [Abstract][Full Text] [Related]
42. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Zhang D; Brodt P Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384 [TBL] [Abstract][Full Text] [Related]
43. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873 [TBL] [Abstract][Full Text] [Related]
44. Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Kim MS; Park MJ; Moon EJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH Cancer Res; 2005 Feb; 65(3):686-91. PubMed ID: 15705860 [TBL] [Abstract][Full Text] [Related]
45. The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme. Schlegel J; Piontek G; Budde B; Neff F; Kraus A Cancer Lett; 2000 Sep; 158(1):103-8. PubMed ID: 10940516 [TBL] [Abstract][Full Text] [Related]
47. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Kim HW; Park IK; Cho CS; Lee KH; Beck GR; Colburn NH; Cho MH Cancer Res; 2004 Nov; 64(21):7971-6. PubMed ID: 15520204 [TBL] [Abstract][Full Text] [Related]
48. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Sun H; Lesche R; Li DM; Liliental J; Zhang H; Gao J; Gavrilova N; Mueller B; Liu X; Wu H Proc Natl Acad Sci U S A; 1999 May; 96(11):6199-204. PubMed ID: 10339565 [TBL] [Abstract][Full Text] [Related]
49. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Panner A; Crane CA; Weng C; Feletti A; Parsa AT; Pieper RO Cancer Res; 2009 Oct; 69(20):7911-6. PubMed ID: 19808964 [TBL] [Abstract][Full Text] [Related]
50. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756 [TBL] [Abstract][Full Text] [Related]
51. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145 [TBL] [Abstract][Full Text] [Related]
52. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Grünwald V; DeGraffenried L; Russel D; Friedrichs WE; Ray RB; Hidalgo M Cancer Res; 2002 Nov; 62(21):6141-5. PubMed ID: 12414639 [TBL] [Abstract][Full Text] [Related]
53. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related]
54. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603 [TBL] [Abstract][Full Text] [Related]
55. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Park S; Zhao D; Hatanpaa KJ; Mickey BE; Saha D; Boothman DA; Story MD; Wong ET; Burma S; Georgescu MM; Rangnekar VM; Chauncey SS; Habib AA Cancer Res; 2009 May; 69(10):4107-11. PubMed ID: 19435890 [TBL] [Abstract][Full Text] [Related]
56. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Cao X; Kambe F; Moeller LC; Refetoff S; Seo H Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791 [TBL] [Abstract][Full Text] [Related]
57. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767 [TBL] [Abstract][Full Text] [Related]
58. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells. Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313 [TBL] [Abstract][Full Text] [Related]
59. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051 [TBL] [Abstract][Full Text] [Related]
60. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins. Welsh N; Makeeva N; Welsh M Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]